Zobrazeno 1 - 10
of 121
pro vyhledávání: '"A. T. Teplyakov"'
Autor:
E. V. Grakova, K. V. Kopeva, S. N. Shilov, E. N. Berezikova, A. A. Popova, M. N. Neupokoeva, E. T. Ratushnyak, V. V. Kalyuzhin, A. T. Teplyakov
Publikováno v:
Бюллетень сибирской медицины, Vol 21, Iss 4, Pp 44-53 (2023)
Aim. To evaluate the role of polymorphisms in adrenoceptor beta 1 (ADRB1) (Arg389Gly, rs1801253) and angiotensin-converting enzyme (ACE) (I/D, rs4343) genes in assessing the effectiveness of β-blocker (carvedilol) and ACE inhibitor (enalapril) thera
Externí odkaz:
https://doaj.org/article/d716a486ddc14e388bcef4acedb28443
Autor:
V. V. Kalyuzhin, A. T. Teplyakov, I. D. Bespalova, E. V. Kalyuzhina, N. N. Terentyeva, E. V. Grakova, K. V. Kopeva, V. Yu. Usov, N. P. Garganeeva, O. A. Pavlenko, Yu. V. Gorelova, A. V. Teteneva
Publikováno v:
Бюллетень сибирской медицины, Vol 21, Iss 3, Pp 181-197 (2022)
Unprecedented advances of recent decades in clinical pharmacology, cardiac surgery, arrhythmology, and cardiac pacing have significantly improved the prognosis in patients with chronic heart failure (CHF). However, unfortunately, heart failure contin
Externí odkaz:
https://doaj.org/article/395ff86b53ec43f383e61188cb0c80d7
Autor:
V. V. Kalyuzhin, A. T. Teplyakov, I. D. Bespalova, E. V. Kalyuzhina, N. N. Terentyeva, I. K. Livshits, V. L. Ostanko, E. V. Grakova, K. V. Kopeva, V. Yu. Usov, N. P. Garganeeva, Yu. V. Gorelova
Publikováno v:
Бюллетень сибирской медицины, Vol 21, Iss 2, Pp 152-167 (2022)
The authors analyzed the problem of diuretic resistance (DR) in patients with chronic heart failure (CHF). Most of the symptoms and signs of CHF are associated with hypervolemia and vascular congestion in the systemic and pulmonary circulation. The s
Externí odkaz:
https://doaj.org/article/5f115b7007404d7eaed8948c1752c0e9
Autor:
E. V. Grakova, K. V. Kopeva, A. T. Teplyakov, M. V. Soldatenko, T. E. Suslova, V. V. Kalyuzhin
Publikováno v:
Бюллетень сибирской медицины, Vol 21, Iss 1, Pp 35-46 (2022)
Aim. To study the prognostic value of high serum concentration of soluble ST2 protein (sST2) in the development of cardiovascular events after endovascular myocardial revascularization and the possibility of using this biomarker as a target for β-bl
Externí odkaz:
https://doaj.org/article/3d1aa2ddcfdd4f25b6cb93326c2f11a6
Autor:
A. V. Yakovlev, S. N. Shilov, E. N. Berezikova, N. F. Yakovleva, A. T. Teplyakov, E. V. Grakova, K. V. Kopeva, I. A. Efremov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 3, Pp 444-449 (2021)
Aim. To study approaches to the treatment of chronic heart failure (CHF) with reduced and mid-range left ventricular ejection fraction (LVEF) in patients with arterial hypertension (AH) against the background of obstructive sleep apnea (OSA).Material
Externí odkaz:
https://doaj.org/article/b5f8828bcb174e7aa24f5a2be766f819
Autor:
A. T. Teplyakov, A. V. Yakovlev, S. N. Shilov, N. F. Yakovleva, E. N. Berezikova, E. V. Grakova, K. V. Kopeva, S. D. Mayanskaya
Publikováno v:
Бюллетень сибирской медицины, Vol 20, Iss 2, Pp 102-112 (2021)
Aim. To study the relationship of obstructive respiratory disorders during sleep with subclinical development of right ventricular dysfunction and pulmonary hypertension, as well as with the risk of an adverse course of chronic heart failure (CHF) wi
Externí odkaz:
https://doaj.org/article/3b81c85f6cf24bc580a0058a842b67e7
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 7 (2022)
Aim. To assess the prognostic role of cardiac biomarkers (galectin-3, soluble ST2 (sST2), and N-terminal pro-brain natriuretic peptide (NT-proBNP)) in risk stratification of adverse cardiovascular events (CVEs) in patients with heart failure (HF) aft
Externí odkaz:
https://doaj.org/article/0ac858a3ded54e839ab447c31f686ec4
Autor:
A. V. Yakovlev, R. S. Chernyshev, K. S. Sakhonchik, S. N. Shilov, E. V. Grakova, K. V. Kop’eva, A. T. Teplyakov, I. A. Efremov, M. S. Kessler, N. F. Yakovleva, I. A. Grebenkina
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 21, Iss 7 (2022)
Aim. To study the associations of hypoxia-inducible factor-1 alpha (HIF-1α) gene polymorphism (rs11549465) with the clinical course of heart failure (HF) with reserved ejection fraction (HFpEF) in patients with obesity and moderate and severe obstru
Externí odkaz:
https://doaj.org/article/64941ec9d2294fd0a3c947e56c1f7dfb
Autor:
S. N. Shilov, E. N. Berezikova, A. A. Popova, E. N. Samsonova, A. T. Teplyakov, E. V. Grakova, K. V. Kopeva, A. V. Molokov, I. V. Yakovleva
Publikováno v:
Медицинский совет, Vol 0, Iss 7, Pp 78-86 (2021)
Introduction. Diabetes mellitus, cardiovascular diseases and osteoporosis are linked by common pathophysiological mechanisms.Objective. To evaluate the effect of alendronate bisphosphonate on cardiovascular outcomes in comorbid patients with ischemic
Externí odkaz:
https://doaj.org/article/2cd46440c1f6435b84c0ea243828fdc1
Autor:
V. V. Kalyuzhin, A. T. Teplyakov, I. D. Bespalova, E. V. Kalyuzhina, N. N. Terentyeva, O. F. Sibireva, E. V. Grakova, V. Yu. Usov, M. A. Osipova
Publikováno v:
Бюллетень сибирской медицины, Vol 20, Iss 1, Pp 129-146 (2021)
The authors of the article have analyzed the problem of advanced heart failure (AHF). Despite significant and, it is not an exaggeration to say, revolutionary achievements in clinical pharmacology, cardiac surgery and implantation arrhythmology, the
Externí odkaz:
https://doaj.org/article/f2cdf1eda40a4b599a8431805e5c3637